New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
16:13 EDTSGENSeattle Genetics reports Q4 EPS (9c), consensus (11c)
Reports Q4 revenue $63.9M, consensus $57.21M.
News For SGEN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 8, 2015
07:08 EDTSGENBaker Bros. raises stake in Seattle Genetics to 24.1%
Baker Bros. Advisors LP disclosed this morning a 24.1% stake in Seattle Genetics, up from the 22.7% stake the fund reported on December 17, 2014. The current position represents 30.17M shares of the biotechnology company focused on antibody-based therapies for the treatment of cancer. Baker Bros. said in the filing that it may make suggestions to Seattle Genetics management regarding financing. The stock closed yesterday up 77c to $38.04.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use